Huijie X. Miao

1665 Kongjiang Road
Yangpu, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Continuous renal replacement therapy attenuates endothelial injury biomarkers in pediatric sepsis: a prospective cohort study.

Continuous renal replacement therapy attenuates endothelial injury biomarkers in pediatric sepsis: a prospective cohort study.

Journal: Renal failure

Published: March 31, 2026

The neuroimmune axis in breast cancer: from mechanistic insights to clinical applications.

The neuroimmune axis in breast cancer: from mechanistic insights to clinical applications.

Journal: BMC medicine

Published: November 06, 2025

Intestine-derived fibroblast growth factor 19 alleviates lipopolysaccharide-induced liver injury by regulating bile acid homeostasis and directly improving oxidative stress.

Intestine-derived fibroblast growth factor 19 alleviates lipopolysaccharide-induced liver injury by regulating bile acid homeostasis and directly improving oxidative stress.

Journal: Journal of intensive medicine

Published: January 14, 2024

The anticancer activity of bile acids in drug discovery and development.

The anticancer activity of bile acids in drug discovery and development.

Journal: Frontiers in pharmacology

Published: December 28, 2023

The death risk of pediatric patients with cancer-related sepsis requiring continuous renal replacement therapy: a retrospective cohort study.

The death risk of pediatric patients with cancer-related sepsis requiring continuous renal replacement therapy: a retrospective cohort study.

Journal: Jornal de pediatria

Published: December 19, 2023

Obeticholic Acid Inhibit Mitochondria Dysfunction Via Regulating ERK1/2-DRP Pathway to Exert Protective Effect on Lipopolysaccharide-Induced Myocardial Injury.

Obeticholic Acid Inhibit Mitochondria Dysfunction Via Regulating ERK1/2-DRP Pathway to Exert Protective Effect on Lipopolysaccharide-Induced Myocardial Injury.

Journal: Advanced biology

Published: October 25, 2023

ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis.

ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis.

Journal: Clinical immunology (Orlando, Fla.)

Published: April 18, 2023

Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells.

Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells.

Journal: Chinese medical journal

Published: December 16, 2022

Lithocholic acid inhibits gallbladder cancer proliferation through interfering glutaminase-mediated glutamine metabolism.

Lithocholic acid inhibits gallbladder cancer proliferation through interfering glutaminase-mediated glutamine metabolism.

Journal: Biochemical pharmacology

Published: July 16, 2022

Continuous renal replacement therapy attenuates polymorphonuclear myeloid-derived suppressor cell expansion in pediatric severe sepsis.

Continuous renal replacement therapy attenuates polymorphonuclear myeloid-derived suppressor cell expansion in pediatric severe sepsis.

Journal: Frontiers in immunology

Published: July 10, 2022

tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L.

tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L.

Journal: Cellular & molecular biology letters

Published: July 09, 2022

Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway.

Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: July 06, 2022

Showing 1-12 of 41

Last Updated: 09/26/2026